Abiopharma

Alvotech og Advanz Pharma fá markaðsleyfi á Evrópska efnahagssvæðinu fyrir Gobivaz, fyrstu hliðstæðuna við Simponi

How to Make Money Using Ai (2026 Guide)

Latest About What Is An Amazon Passkey

Latest About Galaxy Buds3 Pro: Specifications, Release Date, Latest Updates

How Do You Deactivate Instagram? Guide For 2026

Magic Keyboard For iPad Pro: 2026 Updates and Compatibility Features

Koselugo approved in the US for adults with neurofibromatosis type 1

Burning Rock Reports Third Quarter 2025 Financial Results

Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline assets

ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP